Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05009706
Other study ID # Dnr 2020-00295
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date September 6, 2021
Est. completion date March 2025

Study information

Verified date March 2022
Source Karolinska Institutet
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The overall purpose of the randomized controlled study is to evaluate the effects of physical exercise, nutrition and symptom management on physical capacity in older, frail persons with heart failure.


Description:

The randomized controlled study will be conducted in order to evaluate the effects of individual needs of physical exercise, nutrition, and symptom management in patients with heart failure who are frail and older. Patients discharged from a geriatric hospital will be recruited and included after informed consent. Two weeks after hospital discharge patients are randomized to intervention or control group. The intervention period is 3 months. With support from a physioterapeut, dietician and a registered nurse, the intervention will be performed in the participants´ home. Once a week participants will come to the hospital for physical exercise led by a physiotherapist. Once a week or every other week participants will meet a dietician and a nurse. Data will be collected at baseline, and 3 and 6 months after baseline. Data consist of e.g. study flow description, number of eligible patients, number of drop-outs, patients sociodemographic- and clinical data, physical function and performance, nutritional status, symptom burden, self-care, appetite, thirst, health-related quality of life. At 12 months after baseline, data will be collected on hospital admissions, reasons for hospital admissions, length of stay and mortality.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 212
Est. completion date March 2025
Est. primary completion date September 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients at geriatric clinic - Diagnosed with heart failure (independent of Ejection Fraction (EF): both patients with preserved EF or reduced EF can be included - New York Heart Association functional class II - III - Clinical frailty level 4-6 (moderate frailty) - Discharge from hospital to home Exclusion Criteria: - New York Heart Associacion functional class I or IV - Clinical frailty level 1-3 (no/mild frailty) and 7-9 (severe frailty) - The patient is unable to perform gait tests due to visual (see a TV screen at a 3 meter distance), cognitive (assessed by nurse or doctor) or motor impairment (the patient should be able to stand up from sitting and have the ability to walk with or without a walker or other walking aid). - The patient is unable to follow instructions (assessed by nurse or doctor)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Self-care in Older frail Persons with Heart failure Intervention (SOPHI)
Patients who are randomized to the Self Care group will receive oral and written information, advice and support on following activities: excercise (from physiotherapist), nutrition (dietician) and symptom management (nurse), based on patient´s individual needs and abilities. The Self Care group will perform the activities daily at home. Once a week, patients come to the hospital to exercise with the support of a physiotherapist. Once a week or every other week patients will meet (at hospital or by phone) the dietician and nurse to solve possible problems and to follow-up food/nutrition intake and symptoms/symptom management.

Locations

Country Name City State
Sweden Karolinska Universitetssjukhuset, Tema Inflammation och Åldrande Huddinge

Sponsors (2)

Lead Sponsor Collaborator
Karolinska Institutet Karolinska University Hospital

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Other Objective physical activity Measured with a non-invasive miniature electronic logger during 4-5 days per time frame Baseline, 3 and 6 months
Other Subjective physical activity Assessed by the instrument titled "International Physical Activity Questionnaire" (IPAQ). Measure the minutes of physical activity during a day. Baseline, 3 and 6 months
Other Experiences of patients A qualitative interview will be used to collect data on patient´s experiences of the intervention 3 months
Other Self-care Assessed with the questionnaire titled "Self-care of chronic illness inventory" (30 questions).
Minimum score is 28 and maximum score is 150. Higher score indicate better self care
Baseline, 3 and 6 months
Other Appetite Assessed with the questionnaire titled "The Council on Nutrition Appetite Questionnaire" (8 questions)Failure".
Minimum score is 8 and maximum score is 40. Higher score indicate better appetite
Baseline, 3 and 6 months
Other Thirst distress Assessed with the questionnaire titled "Thirst Distress Scale for patients with Heart Failure" (8 questions) Minimum score is 8 and maximum score is 40. Higher score indicate higher thirst distress Baseline, 3 and 6 months
Primary Change in physical performance The "Short Physical Performance Battery" is composed of "standing balance", "gait speed", and "timed repeated chair rise". The total score range from minimum 0 to maximum 12, with higher scores indicating better physical performance. 3 months
Secondary Symptom burden Assessed by the questionnaire titled "The Memorial Symptom Assessment Scale- Heart Failure", that evaluates symptoms experienced by the patient in the last week (a total of 36 symptoms, for example pain, nausea, tiredness). A score of 0 is given to a symptom if it is absent. If the symptom is present, it is rated using a four-point rating scale (1-4) for frequency and severity, and a five-point rating scale (0-4) for distress of the symptom with higher scores indicating greater frequency, more severity and higher distress. For each symptom, the average of the frequency, severity and distress will be calculated to produce the outcome symptom burden (total scores ranging from minimum 0 to maximum 4, with higher scores indicating greater symptom burden). Baseline, 3 and 6 months
Secondary Health related quality of life Assessed with the Euroqol questionnaire titled "The EQ-5D". It comprises five questions about mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Answer options are no problems (score 1), moderate problems (score 2), severe/extreme problems (score 3). The results are converted into a single index value (minimum value 0 to maximum value 1). Higher value indicate better health related quality of life Baseline, 3 and 6 months
Secondary Aerobic capacity/endurance Assessed with the 6-minute walk test, the distance in meters covered over a time of 6 minutes Baseline, 3 and 6 months
Secondary Frailty Assessed by the scale titled "Clinical Frailty Scale". From the minimum value 1 (patient is very fit) to the maximum value 9 (terminally ill). Higher score indicates more frailty Baseline, 3 and 6 months
Secondary Perceived physical effort Assessed with the scale titled "Borg Category Ratio-10 Scale" of perceived exertion.
The minimum value is 0 (nothing at all) to the maximum value 10 (extremely strong or maximal). Higher value indicate worse physical effort
Baseline, 3 and 6 months
Secondary Hand strength Assessed with the hand-gripdynamometer (JAMAR) Baseline, 3 and 6 months
Secondary Hospital readmissions The number of hospital readmissions during a 12 month period will be retrieved from the patients medical record 12 months
Secondary Lower body strength Sit to stand test measure the number of uprising from a chair during 30 seconds Baseline, 3 and 6 months
Secondary Nutrition status Assessed by the "Mini Nutritional Assessment" screening. The total score range from minimum 0 to maximum 14. Higher scores indicate better nutrition status Baseline, 3 and 6 months
Secondary Inflammation marker Plasma C-reactive protein (mg/L), reference interval value below 3 mg/L. Higher value indicate inflammation in the body Baseline, 3 and 6 months
Secondary Sarcopenia Measured by the criteria of European Working Group on Sarcopenia in Older People's Baseline, 3 and 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Recruiting NCT05654272 - Development of CIRC Technologies
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
Completed NCT04549181 - Problem-Solving for Rural Heart Failure Dyads N/A